Cargando…
Use of Levetiracetam in Epileptic Dogs with Chronic Kidney Disease: A Retrospective Study
In human medicine, doses of levetiracetam (LEV) are individualized for patients with epilepsy, depending on the status of the patient’s renal function. However, there are not reports on the individualized dosing of LEV for small animals. The aim of this study is to investigate whether a dose adjustm...
Autores principales: | Gim, So-Yeon, Song, Woo-Jin, Youn, Hwa-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617888/ https://www.ncbi.nlm.nih.gov/pubmed/34822636 http://dx.doi.org/10.3390/vetsci8110263 |
Ejemplares similares
-
Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
por: Ha, Changhee, et al.
Publicado: (2021) -
Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide
por: Muñana, Karen R., et al.
Publicado: (2018) -
Blockade of TASK-1 Channel Improves the Efficacy of Levetiracetam in Chronically Epileptic Rats
por: Kim, Ji-Eun, et al.
Publicado: (2022) -
Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation
por: Lin, Chih-Hsiang, et al.
Publicado: (2015) -
Levetiracetam Versus Levetiracetam Plus Sodium Channel Blockers for Postoperative Epileptic Seizure Prevention in Brain Tumor Patients
por: Watanabe, Noriyuki, et al.
Publicado: (2022)